DEVELOPING COUNTRY VACCINE REGULATORS’ NETWORK (DCVRN)
The Developing Country Vaccine Regulators’ Network (DCVRN) was established in September 2004 by the World Health Organization (WHO).
The DCVRN meets once a year to discuss regulatory issues and its purpose is to contribute to the strengthening of the National Regulatory Authorities (NRA) in developing countries where vaccines are manufactured, particularly in the area of authorization and evaluation of vaccine clinical trials.
During vaccine development, clinical trials may take place in any country regardless of the level of expertise of the NRA. Through the DCVRN, NRAs in developing countries have the opportunity to exchange scientific information and expertise with regulators from well-resourced countries that manufacture vaccines,as well as with regulators in countries targeted for clinical trials and/or vaccine introduction. In addition, participants can also strengthen their procedures for the review of clinical trial protocols and clinical data for new vaccines.